5 unknown. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Unknown 5 |
Follow Hyperpituitarism: new trials by email Literature Review of Hyperpituitarism trials Research Report on Hyperpituitarism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Acromegaly (3) · Hyperprolactinemia (2) · Cardiomegaly (1) · Dyslipidemias (1) · Heart Failure (1) · Hypertrophy (1) · Hypertrophy, Left Ventricular (1) · Schizophrenia (1) · Sexual Dysfunction, Physiological (1) · Weight Gain (1)
Brain Diseases (5) · Central Nervous System Diseases (5) · Endocrine System Diseases (5) · Hypothalamic Diseases (5) · Nervous System Diseases (5) · Pituitary Diseases (5) · Bone Diseases (3) · Bone Diseases, Endocrine (3) · Musculoskeletal Diseases (3) · Pathological Conditions, Signs and Symptoms (2) · Body Weight (1) · Body Weight Changes (1) · Cardiovascular Diseases (1) · Genital Diseases (1)
Aripiprazole (2) · pegvisomant (2) · Octreotide (1) · Paliperidone Palmitate (1) · Risperidone (1) · pasireotide (1)
Asan Medical Center (1) · Erasmus Medical Center (1) · Genovate Biotechnology Co., Ltd., (1) · Si Tianmei (1) · University of Wuerzburg (1)
China (1) · Germany (1) · Netherlands (1) · South Korea (1)
Bruno Allolio, MD (1) · Chen Chih-Ken, PhD (1) · Sebastian Neggers, MD PhD (1)
2014 (1)